Complement levels (CH,,, C,, C, and C1,) were determined in sera of 90 healthy subjects and 200 cancer patients. Complement levels of cancer patients were significantly higher than those of the healthy subjects, but there was a stagelinked increase of complement levels. Patients in remission had nea
Increased levels of soluble complement receptor 1 in serum of patients with liver diseases
β Scribed by S Sadallah; E Giostra; G Mentha; J A Schifferli
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 235 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
with leukemia have high serum levels of sCR1 may indicate Complement receptor type 1 (CR1) is an integral memhigh synthetic and shedding rates of this receptor. 7 brane protein of many hematopoietic cells and is found
In a preliminary study on a small group of patients with in a soluble form in plasma. Preliminary data have indicirrhosis, sCR1 levels were found to be above the normal cated that soluble complement receptor 1 (sCR1) levels range. 7 This observation cannot be attributed to an increased in serum were increased in patients with cirrhosis. In synthesis of sCR1 by hepatocytes, because these cells are this study, sCR1 was measured in patients with various known not to produce it. 9 The concentration of many plasma liver diseases with a newly established enzyme-linked proteins decreases in liver failure because of diminished liver immunosorbent assay (ELISA). sCR1 level was elevated synthesis. The drop in the concentration of these proteins is in chronic active hepatitis C ( 24patients, 62.6 { 31 ng/ an accepted index of liver failure. The concentration of only mL; 31 normal controls, 31.4 { 7.8 ng/mL, P Γ΅ .001), and few large glycoproteins e.g., complement C7 increases in liver in cirrhosis (35 patients, 143.7 { 61 ng/mL, P Γ΅ .001).
failure. 9a Thus, the present study was undertaken to define The levels increased transiently in 3 patients who had whether elevated serum sCR1 might be related to specific Amanita phalloides intoxication. In 25 patients with adliver diseases and to analyze the relationship between the vanced cirrhosis (pretransplantation screening), there level of sCR1 and liver function. were significant inverse correlations between sCR1 and both the prothrombin index (r s Γ 0.60, P Γ΅ .002) and the PATIENTS AND METHODS aminopyrine breath test (r s Γ 0.51, P Γ΅ .01). Following liver transplantation, the levels dropped from 166 { 70 Study Population. The study population included: (1) Thirty-five patients who had cirrhosis on biopsy. The etiology to 49 { 24 ng/mL (P Γ΅ .0001), and serial measurements of cirrhosis was as follows: hepatitis C virus in 13, as demonstrated Abbreviations: CR1, complement receptor 1; sCR1, soluble complement receptor 1;
well plates (Nunc Maxisorp immunoplates, Gibco BRL, Basel, Swit-ELISA, enzyme-linked immunosorbent assay; HBV, hepatitis B virus; PBS, phosphatebuffered saline. zerland) were coated with 100 mL of purified 3D9 (0.3 mg/well, in
π SIMILAR VOLUMES
Recent animal studies show that endothelial cells in liver sinusoids are the main site for removal of sodium hyaluronate from the circulation. Few data with respect to hyaluronate metabolism are available in man. Serum hyaluronate levels were measured in 119 patients with liver disease by a sensitiv
Background: Tumor necrosis factor alpha (TNFβ£) is a proinflammatory cytokine and an important mediator in the pathophysiology of inflammatory bowel disease (IBD). The effects of TNFβ£ are mediated by 2 specific receptors, a 55-kDa protein (TNF-RI) and a 75-kDa receptor (TNF-RII), which are usually bo
## Abstract ## Objective To determine levels of soluble fractalkine (sFkn) in rheumatoid arthritis (RA) patients with and without rheumatoid vasculitis (RV), and to assess the relationship of sFkn levels to disease activity. ## Methods Serum was obtained from 98 RA patients (54 without vasculiti
## Abstract Endostatin is an angiogenesis inhibitor that is an endogenously produced proteolytic fragment of type XVIII collagen. Serum levels of endostatin have been studied extensively in patients with malignant diseases. Recently, elevated serum endostatin levels were observed in patients with s
CA19-9 is a specific tumor marker in patients with gastrointestinal cancer; however, some patients with respiratory disease can have elevated serum levels of CA19-9 as well. In this study we evaluated serum CA19-9 levels of patients with nonmalignant respiratory diseases. We also estimated the progn